Table 5.
Characteristic | OR1 | 95% CI1 | p-value |
---|---|---|---|
Model1 | |||
AGTR | 0.31 | 0.29, 0.33 | < 0.001 |
AIP | |||
Q1(≤ -0.2824) | — | — | |
Q2(-0.2824, -0.0687) | 2.66 | 2.17, 3.26 | < 0.001 |
Q3(-0.0687,0.1634) | 6.16 | 5.08, 7.46 | < 0.001 |
Q4(> 0.1634) | 16.7 | 13.3, 21.0 | < 0.001 |
Model2 | |||
AGTR | 0.30 | 0.28, 0.32 | < 0.001 |
AIP | |||
Q1(≤ -0.2824) | — | — | |
Q2(-0.2824, -0.0687) | 2.56 | 2.11, 3.12 | < 0.001 |
Q3(-0.0687,0.1634) | 5.88 | 4.86, 7.11 | < 0.001 |
Q4(> 0.1634) | 16.3 | 13.0, 20.5 | < 0.001 |
Model3 | |||
AGTR | 0.30 | 0.27, 0.33 | < 0.001 |
AIP | |||
Q1(≤ -0.2824) | — | — | |
Q2(-0.2824, -0.0687) | 1.81 | 1.35, 2.44 | < 0.001 |
Q3(-0.0687,0.1634) | 3.32 | 2.61, 4.21 | < 0.001 |
Q4(> 0.1634) | 7.27 | 5.47, 9.65 | < 0.001 |
Model1 No variables were adjusted
Model2 Adjusted for age, gender, race, and income poverty ratio
Model3 Adjusted for BMI, physical activity, diabetes mellitus, alkaline phosphatase, mercury, cadmium, transaminases, smoking, drinking, protein intake, vitamin C and potential confounders of LDL on a previous basis based on model2
AGTR albumin to glutamyl transpeptidase ratio, AIP plasma atherogenicity index
1OR Odds Ratio, CI Confidence Interval